Faro Health is at the forefront of revolutionizing clinical trial design through its innovative, cloud-based software platform. The company is dedicated to transforming how clinical protocols are developed by integrating all stakeholders within the clinical trials ecosystem. This includes sponsor and CRO ClinOps teams, research sites, vendors, patients, and laboratories, all connected through a singular, cohesive software solution. Through groundbreaking technology, Faro Health is streamlining the traditionally complex and manual processes involved in designing and authoring clinical studies for biopharmaceutical and medical device companies. The platform empowers clinical development teams to create, refine, and manage clinical protocols in a digital-native environment, significantly reducing manual labor and enhancing operational efficiency. By digitizing protocol design, Faro Health provides actionable insights aimed at lessening the burden on patients and clinicians, decreasing the costs associated with clinical trials, and simplifying overall study complexity.
The core of Faro Health's innovation lies in its ability to standardize, automate, and streamline the challenges inherent in clinical trials. The platform utilizes an integrated clinical development environment that simplifies the creation of complex clinical studies by leveraging smart digital protocols. It offers in-context and intuitive insights during the authoring process, enabling clinical researchers to optimize study designs based on data-driven decisions. Faro Health's technology facilitates the design of complex clinical trials using modular building blocks, combined with data-driven insights to orchestrate and automate operationally intricate trials. This approach not only accelerates the development of novel medicines but also ensures that clinical trials are operationally efficient, avoiding delays and generating trustworthy data. The company's commitment to innovation is further underscored by its focus on integrating AI and automation to reduce costs, accelerate timelines, and improve patient experiences, thereby establishing a new standard for the future of clinical research.
United States only